Cargando…

Evidence for Non-Cancer-Specific T Cell Exhaustion in the Tcl1 Mouse Model for Chronic Lymphocytic Leukemia

The reinvigoration of anti-cancer immunity by immune checkpoint therapies has greatly improved cancer treatment. In chronic lymphocytic leukemia (CLL), patients as well as in the Tcl1 mouse model for CLL, PD1-expressing, exhausted T cells significantly expand alongside CLL development; nevertheless,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parigger, Thomas, Gassner, Franz Josef, Scherhäufl, Christian, Bakar, Aryunni Abu, Höpner, Jan Philip, Hödlmoser, Alexandra, Steiner, Markus, Catakovic, Kemal, Geisberger, Roland, Greil, Richard, Zaborsky, Nadja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268419/ https://www.ncbi.nlm.nih.gov/pubmed/34206229 http://dx.doi.org/10.3390/ijms22136648

Ejemplares similares

Chronic lymphocytic leukaemia induces an exhausted T cell phenotype in the TCL1 transgenic mouse model
por: Gassner, Franz J, et al.
Publicado: (2015)

AID Contributes to Accelerated Disease Progression in the TCL1 Mouse Transplant Model for CLL
por: Schubert, Maria, et al.
Publicado: (2021)

Alternative splice variants of AID are not stoichiometrically present at the protein level in chronic lymphocytic leukemia
por: Rebhandl, Stefan, et al.
Publicado: (2014)

Exome sequencing of the TCL1 mouse model for CLL reveals genetic heterogeneity and dynamics during disease development
por: Zaborsky, Nadja, et al.
Publicado: (2018)

Detecting Bacterial–Human Lateral Gene Transfer in Chronic Lymphocytic Leukemia
por: Akimova, Ekaterina, et al.
Publicado: (2022)

TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia
por: Catakovic, Kemal, et al.
Publicado: (2017)

RNA Editing Alters miRNA Function in Chronic Lymphocytic Leukemia
por: Gassner, Franz J., et al.
Publicado: (2020)

A POLE Splice Site Deletion Detected in a Patient with Biclonal CLL and Prostate Cancer: A Case Report
por: Steiner, Markus, et al.
Publicado: (2021)

APOBEC3 signature mutations in chronic lymphocytic leukemia
por: Rebhandl, S, et al.
Publicado: (2014)

Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study
por: Egle, Alexander, et al.
Publicado: (2018)

T cell exhaustion: from pathophysiological basics to tumor immunotherapy
por: Catakovic, Kemal, et al.
Publicado: (2017)

AID induces intraclonal diversity and genomic damage in CD86(+) chronic lymphocytic leukemia cells
por: Huemer, Michael, et al.
Publicado: (2014)

Validation of genetic variants from NGS data using deep convolutional neural networks
por: Vaisband, Marc, et al.
Publicado: (2023)

TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemia
por: Szenes, Eva, et al.
Publicado: (2020)

Lysine Residue at Position 22 of the AID Protein Regulates Its Class Switch Activity
por: Geisberger, Roland, et al.
Publicado: (2012)

Investigating epigenetic effects of activation-induced deaminase in chronic lymphocytic leukemia
por: Schubert, Maria, et al.
Publicado: (2018)

CD4+ T cells, but not non-classical monocytes, are dispensable for the development of chronic lymphocytic leukemia in the TCL1-tg murine model
por: Kocher, T, et al.
Publicado: (2016)

RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia
por: Gassner, Franz J., et al.
Publicado: (2020)

Mouse models to decipher anti-tumor immunity
por: Parigger, Thomas, et al.
Publicado: (2019)

CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cells
por: Zaborsky, Nadja, et al.
Publicado: (2016)

SAMHD1 restrains aberrant nucleotide insertions at repair junctions generated by DNA end joining
por: Akimova, Ekaterina, et al.
Publicado: (2021)

CAR T-Cell Therapy in Hematological Malignancies
por: Haslauer, Theresa, et al.
Publicado: (2021)

miRNA-Based Therapeutics in the Era of Immune-Checkpoint Inhibitors
por: Huemer, Florian, et al.
Publicado: (2021)

Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia
por: Gassner, Franz Josef, et al.
Publicado: (2010)

Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial Intelligence
por: Huemer, Florian, et al.
Publicado: (2020)

Effective Tcl/Tk programming: writing better programs with Tcl and Tk
por: Harrison, Mark, et al.
Publicado: (1998)

Tcl and the Tk toolkit /
por: Ousterhout, John K.
Publicado: (1994)

Tcl and the Tk toolkit
por: Ousterhout, John K
Publicado: (1994)

Tcl/Tk tools
por: Harrison, M, et al.
Publicado: (1997)

Tcl and the Tk toolkit
por: Ousterhout, John K, et al.
Publicado: (2009)

Practical programming in Tcl and Tk
por: Welch, Brent B, et al.
Publicado: (2003)

Tcl/Tk in a Nutshell
por: Raines, Paul, et al.
Publicado: (2009)

Practical programming in Tcl and Tk
por: Welch, Brent B
Publicado: (1995)

Tcl 85 Network Programming
por: Kocjan, Wojciech, et al.
Publicado: (2010)

TclTk Pocket Reference
por: Raines, Paul
Publicado: (1998)

Practical programming in Tcl & Tk
por: Welch, Brent B
Publicado: (2000)

Functional Analysis of Tcl1 Using Tcl1-Deficient Mouse Embryonic Stem Cells
por: Miyazaki, Tatsushi, et al.
Publicado: (2013)

Correction: Functional Analysis of Tcl1 Using Tcl1-Deficient Mouse Embryonic Stem Cells
por: Miyazaki, Tatsushi, et al.
Publicado: (2013)

Crystal Structure of Murine Tcl1 Oncoprotein and Conserved Surface Features of the Molecules of the Tcl1 Family
por: Petock, John M., et al.
Publicado: (2002)

Combined ibrutinib and venetoclax treatment vs single agents in the TCL1 mouse model of chronic lymphocytic leukemia
por: Kater, Arnon P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sfbjs938p5kcvkr85ccdhn0u54